⚠️ Uptrend Under Pressure Severe risk · 99 · Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY) Full briefing → Jul 28
Simple research view

WAT · Waters Corporation

$371.20 latest stored close
Detected setup Wyckoff SOS

Watch · Quality 22/100

Ask about WAT

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

Scans / Health Technology / WAT

$WAT

Waters Corporation

Waters Corporation is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $36B.

Neutral · 61 Health Technology Medical Specialties stock Stage 3 · Topping Base 1 Data 1h 57m ago
$371.20 latest close
Council read · 6 methods

Watch — evidence is building

0 buyable · 3 watch · 3 avoid. Review the observed passes and blockers before reading the chart.

Earnings-risk mode

Pre-earnings setup

Wednesday, July 29, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

WAT-0.93%
Sector proxy · XLV+0.51%
Broad market · SPY+0.02%
Same completed session window ending 2026-07-27. WAT was -1.44 points vs XLV. -0.95 points vs SPY.
CatalystUnavailable Stock reactionNegative Sector reactionSupportive Opening surgeUnavailable Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.
Price $371.20 Jul 27 close
52W High $414.15 -10.4%
52W Low $275.05
Wks Since High 33w
Base Depth -31.7%
Base B1
SMA 50 $364.15
SMA 200 $353.41
Avg Vol 929,353
RS Rank 42
RS vs High -17.8%
RS Slope +0.9% ▲
Grp Rank #48/64
ADR% 2.9%
ATR(14) $11.67 (3.1%)
Rel Vol (today) 0.86×
Vol Pace N/A
U/D Vol 1.48
A/D Days 16A / 13D
A/D Rating A
VDU Bars 0/10 d
Earnings tmrw
$275.05
$414.15 69%

WAT Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for WAT.

Create Free Account
Setup Quality D 2/7 signals
Jul 24: 68 (Flat Base)Jul 27: 51 (Wyckoff SOS)Jul 28: 51 (Wyckoff SOS)Jul 28: 51 (Wyckoff SOS)51 Score trend
✗ Stage 3 · Topping ✗ Power Trend ✗ RS New High ✓ Trend 6/8 ✗ No Pattern ✗ CANSLIM 46.4 (D) ✓ Gatekeeper Base #1 (A)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$WAT · $371.20 · as of 2026-07-27 · multi-factor read
61
/ 100
Neutral

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$364.15 ↑
100-day$338.56 ↑
200-day$353.41 ↑
Bullish (50 > 200)

RSI (14)

Reading50.9 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-0.807

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width39% · 6.0%
Squeeze — volatility compressing

Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol1.48 · Neutral
Rel volume0.86×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $384.40swing level
R · $389.82swing level
R · $401.10swing level
Price · $371.20now
S · $367.12swing level
S · $351.77swing level
S · $323.85swing level

Fibonacci · Uptrend swing

23.6%$364.69
38.2%$349.03
50.0%$336.38
61.8%$323.73
78.6%$305.72

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for WAT — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Weekly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? 💬 Ask a Legend about WAT
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 3 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini D

Trend-template read: fails 150-day MA > 200-day MA.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $371.20, MA150 $347.93, MA200 $353.41
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $364.15, MA150 $347.93, MA200 $353.41
Failing evidence
1.2 150-day MA > 200-day MAMA150 $347.93 vs MA200 $353.41
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 41
5/12 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high10.4% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 3.14%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-40.4% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 41
2/8 checks
Avoid
Weinstein D

Stage-analysis read: topping (Stage 3) is not an advancing Stage 2.

Passing evidence
Price above 30-week MA (200-day proxy)Price $371.20 vs MA200 $353.41
Not extended from 52-week high (≤ 30% below)10.4% below 52-week high
Failing evidence
Stage 2 (Advancing phase) confirmedStage 3 (Topping)
30-week MA trending upwardFrom weekly scan context
3/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$371.20
Distance from 52-week high10.4% below high
Failing evidence
Relative strengthRS 41
Volume vs average0.86x
3/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$371.20
Distance from 52-week high10.4% below high
Failing evidence
Relative strengthRS 41
Volume vs average0.86x
3/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$371.20
Distance from 52-week high10.4% below high
Failing evidence
Relative strengthRS 41
Volume vs average0.86x
3/6 checks
Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
106RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +3 A
A: 17 D: 14 Net: +365 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini SEPA criteria · 2/7 met
C 2/7 SEPA
Separate score from the 8-point Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ -40%
Revenue growth ≥20% YoY +7%
Gross margin ≥30% 55%
ROE ≥17% 8%
RS rating ≥80 (leadership) 41
Stage 2 uptrend (Weinstein) Stage 3
Within 25% of 52W high -10.4%

Method Playbook

📋 Trade it like O'Neil EXACT LEVELS · PRO
Minervini O'Neil Livermore Weinstein Darvas Wyckoff
O'Neil D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro level
Published-method rule: Use the proper base pivot or handle high after CANSLIM leadership and market-direction checks are satisfied.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a breakout through the pivot on volume at least 40% above average; the valid buy zone ends 5% above the pivot.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Use the setup's structural stop with a hard 7–8% maximum-loss ceiling from the actual entry.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Protect progress under constructive support such as the 21-day or 10-week line; a stop may ratchet higher but never lower.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on the hard loss limit, a decisive support break, or a rule-based climax/distribution signal; a normal 20–25% advance is reviewed rather than assumed permanent.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Wyckoff SOS ⚠ Extended past buy zone ⚠ Not actionable yet
50.8 score
RS Score 41
Trend 6/8
CANSLIM 46.4* (D)
range low: 294.829 range high: 346.664 range pct: 0.176 sos thrust: 0.08 sos vol ratio: 1.67 sos bars ago: 20 near lps: ✓ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS

SOS: breakout above range_high=346.66, thrust=8.0%, vol=1.7x avg, lps=near, 20 bars ago | Moderate trend (6/8) | High-confidence pattern (85%) | Recent gap-up (2d ago) | Readiness 53/100 (early) | CANSLIM 46.4 (D) | ⚠ Extended past buy zone; Not actionable yet

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

1/7 universals met
Why these seven? → The Universal Edge

Minervini Trend Template

6/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $371.20 vs SMA150 $347.93 / SMA200 $353.41
SMA 150 above SMA 200 SMA150 $347.93 vs SMA200 $353.41
SMA 200 trending up Slope +6.95 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $364.15
Price above SMA 50 $371.20 vs SMA50 $364.15
30%+ above 52W low +35.0% from $275.05
Within 25% of 52W high -10.4% from $414.15
RS score above 70 RS 41

Fundamentals

52W Range
69%
Mkt Cap SEC
36.4B
EPS QoQ
-40%
Rev YoY
+7%
ROE
8%
Gross Margin
55%
D/E
0.55
EPS TTM
$10.76
P/E TTM
34.5x
Float
98M
Insider
No Buy

Company

Legend AI snapshot
Waters Corporation
WAT · NYSE · Health Technology · Medical Specialties
$371.20latest close $36.4Bmarket cap 42RS rank 51setup score
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
D 46.4* CANSLIM * disqualified on C, M
C · Curr. EPS
20
A · Annual EPS
65
N · New Highs
40
S · Supply/Demand
70
L · Leader RS
41
I · Inst. Spons.
50
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
7/8
W. RS
72
W. Support
$282.77
W. Resist
$396.58
Weekly Structure

Scan History

20× streak
Jul 24: 68 (Flat Base)Jul 27: 51 (Wyckoff SOS)Jul 28: 51 (Wyckoff SOS)Jul 28: 51 (Wyckoff SOS)51
Jul 28
Wyckoff SOS ✓ Gate
51
Jul 28
Wyckoff SOS ✓ Gate
51
Jul 27
Wyckoff SOS ✓ Gate
51 0.0%
Jul 24
Flat Base ✓ Gate
68 -0.9%

Get the full picture on WAT

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial